Abstract
Purpose
The present study investigated the prognostic significance of tumor size in gastric carcinoma patients.
Methods
Nine hundred seventy-three gastric carcinoma patients who underwent curative gastrectomy were included and hospital records were reviewed to determine the relationship between tumor size and survival.
Results
First, the patients were divided based on the mean value of the tumor size in respective stages to control selection bias. Only in stages I and III was tumor size a significant independent prognostic factor. Second, we analyzed the appropriate cutoff value for the large tumor. The minimum criterion for a large tumor, which was determined by the receiver-operating characteristic curve for cancer-related death, was 3.5 cm. There were significant differences between patients with large and small tumors with respect to depth of invasion, number of lymph node metastasis, and stage of disease.
Conclusions
Tumor size serves as an indicator of prognosis in gastric cancer patients and a tumor size of 3.5 cm can be used as a significant lower limit of standard size criterion.
Similar content being viewed by others
References
Moriguchi S, Maehara Y, Korenaga D et al (1992) Prediction of survival time after curative surgery for advanced gastric cancer. Eur J Surg Oncol 18:287–292
Nakamura K, Ueyama T, Yao T et al (1992) Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer 70:1030–1037, doi:10.1002/1097-0142(19920901)70:5<1030::AID-CNCR2820700504>3.0.CO;2-C
Adachi Y, Oshiro T, Mori M et al (1997) Tumor size as a simple prognostic indicator for gastric carcinoma. Ann Surg Oncol 4:137–140, doi:10.1007/BF02303796
Kobayashi O, Tsuburaya A, Yoshikawa T et al (2006) The efficacy of gastrectomy for large gastric cancer. Int J Clin Oncol 11:44–50, doi:10.1007/s10147-005-0535-4
Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1:10–24
Sobin LH, Wittekind C (2002) UICC/AJCC TNM classification of malignant tumors, 6th edn. Wiley-Liss, New York
Japanese Research Society for Gastric Carcinoma (1995) Microscopic findings. In: Nishi M, Omori Y (eds) Japanese classification of gastric carcinoma. Kanehara, Tokyo, pp 3–13
Yokota T, Ishiyama S, Saito T et al (2002) Is tumor size a prognostic indicator for gastric carcinoma? Anticancer Res 22:3673–3677
Saito H, Osaki T, Murakami D et al (2006) Macroscopic tumor size as a simple prognostic indicator in patients with gastric cancer. Am J Surg 192:296–300, doi:10.1016/j.amjsurg.2006.03.004
Yasui A, Hirase Y, Miyake M et al (1973) Pathology of superficial spreading type of gastreic cancer. To Cho 8:1305–1310
Kodama Y, Inokuchi K, Soejima K et al (1983) Growth patterns and prognosis in early gastric carcinoma. Superficially spreading and penetrating growth types. Cancer 51:320–326, doi:10.1002/1097-0142(19830115)51:2<320::AID-CNCR2820510226>3.0.CO;2-#
Kitamura K, Yamaguchi T, Okamoto K et al (1996) Superficial spreading type of early gastric cancer. Br J Cancer 74:1834–1837
Imai M, Kondo Y, Osawa S et al (2003) Clinicopathological characteristics of superficial spreading type early gastric cancer. J Surg Oncol 83:94–98, doi:10.1002/jso.10229
Maehara Y, Oiwa H, Sakaguchi Y et al (1995) Surgical treatment and prognosis for patients with gastric cancer lesions larger than ten centimeters in size. Oncology 52:35–40
Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425, doi:10.1007/BF01655804
Roviello F, Marrelli D, Manzoni G et al (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90:1113–1119, doi:10.1002/bjs.4164
Yamamura Y, Nakajima T, Ohta K et al (2002) Determining prognostic factors for gastric cancer using the regression tree method. Gastric Cancer 5:201–207, doi:10.1007/s101200200035
Yoshikawa T, Tsuburaya A, Kobayashi O et al (2001) Should scirrhous gastric carcinoma be treated surgically? Clinical experiences with 233 cases and a retrospective analysis of prognosticators. Hepatogastroenterology 48:1509–1512
Nashimoto A, Nakajima T, Furukawa H et al (2003) Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21:2282–2287, doi:10.1200/JCO.2003.06.103
Kinoshita T, Konishi M, Nakagohri T et al (2003) Neoadjuvant chemotherapy with S-1 for scirrhous gastric cancer: a pilot study. Gastric Cancer 6(Supp 1):40–44, doi:10.1007/s10120-003-0220-0
Songun I, Keizer HJ, Herman J et al (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. Eur J Cancer 35:558–562, doi:10.1016/S0959-8049(98)00429-8
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jun, K.H., Jung, H., Baek, J.M. et al. Does tumor size have an impact on gastric cancer? A single institute experience. Langenbecks Arch Surg 394, 631–635 (2009). https://doi.org/10.1007/s00423-008-0417-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-008-0417-0